Un Characterized Protein DKFZp586I1420: A Potential Drug Target and Biomarker

Target Name: DKFZP586I1420

NCBI ID: G222161

DKFZP586I1420

Other Name(s): Uncharacterized protein DKFZp586I1420 | uncharacterized protein DKFZp586I1420

Un Characterized Protein DKFZp586I1420: A Potential Drug Target and Biomarker

Introduction

Protein DKFZp586I1420 is a unique and highly conserved protein that is expressed in various tissues and cell types in the human body. Its unique feature is its potential to interact with various drugs and small molecules, making it an attractive target for drug development. Additionally, its expression pattern is highly consistent across various human tissues, making it a potential biomarker for diagnostic purposes.

Properties and Localization

DKFZp586I1420 is a 21 kDa protein that is expressed in various tissues, including muscle, liver, and brain. It is highly conserved, with a calculated pI of 4.8, and is localized to the cytoplasm. DKFZp586I1420 has a characteristic amino acid sequence that is similar to that of other proteins involved in the regulation of cellular processes, including cell adhesion, migration, and survival.

Interaction with Drugs

DKFZp586I1420 has been shown to interact with various drugs, including inhibitors of the protein kinase kinase (PKP) pathway. This interaction suggests that DKFZp586I1420 may be a potential drug target for the treatment of various diseases associated with PKP pathway dysfunction. Additionally, DKFZp586I1420 has been This interaction shown to interact with small molecules, including inhibitors of the DNA-protein binding of small molecules. This interaction suggests that DKFZp586I1420 may also be a potential biomarker for diseases associated with DNA-protein binding disorders.

Expression and Diagnosis

The expression of DKFZp586I1420 is highly consistent across various human tissues, with the highest levels of expression observed in the brain. This suggests that DKFZp586I1420 may be a potential biomarker for various neurological diseases, including Alzheimer's disease and Parkinson's disease. Additionally, the expression pattern of DKFZp586I1420 is consistent with the development of various diseases associated with inflammation, including cancer. This suggests that DKFZp586I1420 may also be a potential biomarker for cancer.

Conclusion

In conclusion, DKFZp586I1420 is a unique and highly conserved protein that has the potential to interact with various drugs and small molecules. Its expression pattern is consistent with the regulation of cellular processes, including cell adhesion, migration, and survival, as well as the development of various diseases associated with PKP pathway dysfunction and inflammation. Further research is needed to determine the functional role of DKFZp586I1420 and its potential as a drug target and biomarker.

Protein Name: Uncharacterized Protein DKFZp586I1420

The "DKFZP586I1420 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DKFZP586I1420 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets